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Abstract
Context: Impaired social cognition is a cardinal feature of Autism Spectrum Disorders (ASD) and Schizophrenia (SZ).
However, the functional neuroanatomy of social cognition in either disorder remains unclear due to variability in primary
literature. Additionally, it is not known whether deficits in ASD and SZ arise from similar or disease-specific disruption of the
social cognition network.
Objective: To identify regions most robustly implicated in social cognition processing in SZ and ASD.
Data Sources: Systematic review of English language articles using MEDLINE (1995–2010) and reference lists.
Study Selection: Studies were required to use fMRI to compare ASD or SZ subjects to a matched healthy control group,
provide coordinates in standard stereotactic space, and employ standardized facial emotion recognition (FER) or theory of
mind (TOM) paradigms.
Data Extraction: Activation foci from studies meeting inclusion criteria (n=33) were subjected to a quantitative voxel-based
meta-analysis using activation likelihood estimation, and encompassed 146 subjects with ASD, 336 SZ patients and 492
healthy controls.
Results: Both SZ and ASD showed medial prefrontal hypoactivation, which was more pronounced in ASD, while
ventrolateral prefrontal dysfunction was associated mostly with SZ. Amygdala hypoactivation was observed in SZ patients
during FER and in ASD during more complex ToM tasks. Both disorders were associated with hypoactivation within the
Superior Temporal Sulcus (STS) during ToM tasks, but activation in these regions was increased in ASD during affect
processing. Disease-specific differences were noted in somatosensory engagement, which was increased in SZ and
decreased in ASD. Reduced thalamic activation was uniquely seen in SZ.
Conclusions: Reduced frontolimbic and STS engagement emerged as a shared feature of social cognition deficits in SZ and
ASD. However, there were disease- and stimulus-specific differences. These findings may aid future studies on SZ and ASD
and facilitate the formulation of new hypotheses regarding their pathophysiology.
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Introduction
Autism and psychotic disorders have historically been consid-
ered as related diagnostic entities. One of the innovations of the
DSM-III in the late 1970s was to separate autism spectrum
disorders (ASD) from schizophrenia (SZ) into different diagnostic
categories. Although this distinction has many practical advantag-
es, it is currently being reconsidered in view of emerging evidence
about common neurobiological processes in both disorders [1–3].
Impairment in social cognition is a cardinal feature of the clinical
presentation of both ASD and SZ [4–8]. The term social cognition
refers to a complex set of processes subserving adaptive social
interaction which depend on ‘‘theory of mind’’, or in other words, the
ability to make correct attributions of the mental states of others
[9–10]. Theory of mind (ToM) broadly refers to three types of
attributions: attribution of epistemic mental states (e.g. beliefs),
attribution of intentions or motivations and attribution of affective
states. A range of tasks have been developed to map on these core
mentalising domains. Facial emotion recognition (FER) relates to the
ability to infer the emotional state of others, and although it measures
a core dimension of ToM, it is usually mentioned separately. We will
follow this convention here for ease of reference to the existing
literature. Similarly, we will use the term ToM to collectively refer to
tasks of epistemic (e.g. false beliefs) or intention attribution and tasks
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25322that involve more than one ToM domain (e.g. the attribution of
mental states and intentions to animated geometric figures).
Neurobiological models of social cognition implicate an extended
neural network in processing social stimuli [11–15]. Regions most
consistently involved are the medial and ventrolateral prefrontal
cortex (PFC), ventral temporal regions around the superior
temporal sulcus (STS), occipitotemporal regions (particularly within
the fusiform gyrus), the temporoparietal junction (TPJ), and limbic
structures, especially the amygdala. These regions are intercon-
nected and have additional connectivity with somatosensory
cortices and subcortical structures such as the thalamus. There is
emerging consensus for relative regional specialization within this
extended network. Involvement of the medial PFC in social
cognition is elicited by multiple tasks that require conscious
attribution or judgment of mental states, dispositional traits or
intentions of one’s self or of others [16]. Engagement of the
ventrolateral PFC relates primarily to the contextual or social
appropriateness of responses to social cues [17–19]. Regions
surrounding the TPJ have systematically been associated with social
cognition tasks requiring participants to ‘‘think about other people’s
thoughts’’orinotherwords,totake athirdpersonperspectiveabout
others’ affective or cognitive states [20,21]. Activation in regions
around the STS has been reliably associated with salient biological
movement, including changeable characteristics of human facial
features, which can be used to infer affective or intentional states
[22,23]. Similarly, somatosensory cortices are thought to contribute
to social cognition by invoking or ‘‘mirroring’’ internal represen-
tations of affective states [24]. The amygdala is thought to
contribute to social cognition by mediating arousal [25] or
biological salience [26] associated with stimuli.
Current reviews of the neural basis of social cognition deficits in
SZ [27,28] and ASD [29] have implicated most, if not all the
regions within this network. However, the current literature has
two significant limitations. Firstly, existing reviews, which are
mostly narrative, highlight the variability in the findings from
individual studies, but do not provide an integrated model of the
functional neuroanatomy of social cognition in either SZ or ASD.
Secondly, there are no neuroimaging studies to date directly
comparing patients with ASD or SZ, with the single exception of
Pinkham et al [30]. The authors compared SZ and ASD patients
while performing a functional magnetic resonance imaging (fMRI)
task requiring participants to judge the trustworthiness of human
faces; both patient groups showed reduced activation in the
amygdala and ventrolateral PFC.
The aims of this study were to synthesize existing fMRI data
using a meta-analytic approach in order to (a) identify regions
most robustly implicated in social cognition processing in SZ and
ASD and (b) to draw inferences about differences and similarities
in the neural correlates of social cognition between the two
disorders. Our key predictions were that during tasks of social
cognition both disorders would be associated with reduced
engagement within PFC regions associated with mentalising, and
that similar functional disruption would also be observed in limbic
regions, particularly the amygdala. We also hypothesized that in
SZ, PFC dysfunction would be associated with reduced down-
regulation of more posterior brain regions involved in the
attribution of salience to biological social cues (e.g. facial affect).
Materials and Methods
Data sources and inclusion criteria
The study design and report adhered to the PRISMA Statement
guidelines (supporting information Table S1 and Figure S1). The
search method and inclusion criteria were specified in advance,
informed by existing meta-analyses [1,31,32]. All identified articles
were reviewed for eligibility by at least two authors, and decisions
for inclusion were made by consensus. Data was extracted
independently from each study by the first author, and was
subsequently reviewed by a second author.
Studies investigating FER or ToM in subjects with ASD (including
autism, Asperger’s Syndrome and pervasive developmental disorder
not otherwise specified) or SZ were identified through a computerized
literature search using Medline. We reviewed all papers in English
language published up to 2010. The following search keywords were
employed: ‘‘autism’’, ‘‘schizophrenia’’, ‘‘asperger’’, and ‘‘facial emo-
tion’’, ‘‘emotional processing’’, ‘‘social cognition’’, ‘‘theory of mind’’,
‘‘mentalization’’, ‘‘irony’’, ‘‘empathy’’, ‘‘fMRI’’ and their combinations
and differing terminations, as well as terms specifying individual facial
affect (fear, happiness, sadness, anger and disgust). The reference lists of
these papers were searched for additional articles.
In order to meet inclusion criteria, studies were required to (a)
report comparisons between ASD or SZ patients and matched
healthy controls, (b) employ functional magnetic resonance
imaging (fMRI), (c) use image subtraction methodology to identify
foci of task-related neural changes contrasting an active and
control condition, and (d) report their results in standard
stereotactic coordinates (either Talairach or Montreal Neurolog-
ical Institute space). Studies not fulfilling these requirements were
excluded. No age, gender or treatment restrictions were applied.
Additionally, facial affect processing studies were included if they
used human facial identities as stimuli in both active and control
condition (as opposed to geometric shapes) and were excluded if
they used facial stimuli to investigate processes not directly involved
in emotional processing, such as working memory or attention. As
the majority of FER studies used negatively valence facial
expressions (anger, fear, sadness) we focused exclusively on these
to minimize heterogeneity due to valence [33].
Information extracted from each included: a) foci of task-related
neural changes contrasting an active and control condition between
either patient group (ASD or SZ) and healthy controls b)a description
of each task and the selected contrast c) clinical Information
concerning age, gender, diagnosis, symptom scales, illness duration
and treatment, and matching of the healthy control group.
Quantitative meta-analytical voxel-based procedure
We used one contrast from each study as shown in Tables 1 and
2, and we accepted results as significant based on the threshold
employed in the original studies.
Activation Likelihood Estimation procedure
Coordinates from FER and ToM studies were analysed separately
following the Activation Likelihood Estimation (ALE) technique
implemented in GingerALE 2.0.4 (http://brainmap.org/Ale). This
version uses a random effect model and weighting for sample size of the
original studies [34]. Coordinates of the foci of activation reported in
the original studies were transformed into Talairach space using the
Lancaster transform (icbm2tal tool) in GingerALE. For each study,
peaks were modelled as the centre of a 3D Gaussian distribution and a
modelled activation (MA) map was then computed. ALE scores from
the convergent MA maps were then calculated on a voxel-by-voxel
basis to test for convergent (random-effects) rather than study specific
foci (fixed-effects). All ALE data processing was performed using
the BrainMap Search and View software (http://brainmap.org). The
threshold of statistical significance was set at p,0.05, with False
Discovery Rate (FDR) correction for multiple comparisons and a
minimum cluster size of 80 mm
3. Each ALE map was imported into
Mango (http://ric.uthscsa.edu/mango) and overlaid on an anatomical
Template (http://www.brainmap.org/ale/colin1.1.nii) for representa-
Social Cognition in SZ and ASD
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Brodmann areas (BA) were identified using the standard Talairach
and Tournoux [35] stereotactic anatomic brain atlas. Finally, in order
to compare diagnostic groups, the ALE Maps for SZand ASD for each
experimental design (e.g. ALE map for ASD FER vs ALE map for
SZ FER) were directly contrasted using subtraction meta-analysis
procedure implemented in GingerALE version 1.1 [34]. Regions in
which the two diagnostic groups differed were defined at p,0.05 with
FDR correction and a minimum cluster size of 200 mm
3.
Demographic data analysis
Student t tests (two-tailed) or chi-square tests were used to compare
the distribution of continuous and categorical demographic variables
between the two groups. Only variables which displayed group
Table 1. Details of studies included in the meta-analysis for facial emotion recognition tasks.
Reference
Patients/
Controls Task Contrast used Matching
Autism Spectrum Disorders
Hall et al, 2010 [60] 12/12 Implicit Anxious.Neutral faces Gender, age, non-verbal IQ
Monk et al, 2010 [61] 12/12 Implicit Sad.Neutral faces Gender, age, handedness, IQ
Deeley et al, 2007 [62] 9/9 Implicit Fear.Neutral faces Gender, age, verbal IQ
Ashwin et al, 2007 [63] 13/13 Implicit Fear.Scrambled faces Gender, age, handedness
Critchley et al, 2000 [64] 9/9 Implicit and Explicit Angry.Neutral faces Gender, age, IQ
Schizophrenia
Rauch et al, 2010 [65] 12/12 Implicit Sad.Neutral faces Age, handedness
Dowd et al, 2010 [66] 32/40 Explicit valence rating
task
Negative.Neutral Gender, age, handedness, parental
education
Seiferth et al, 2009 [67] 12/12 Explicit labeling task Fearful.Neutral faces Gender, age, handedness, parental
education
Reske et al, 2009 [68] 18/18 Emotion discrimination task Sad.Neutral faces Gender, age, parental education
Michalopoulou et al, 2008 [69] 11/9 Implicit Fearful.Neutral faces Age, handedness, education
Hall et al, 2008 [70] 19/24 Implicit Fearful.Neutral faces Gender, age, IQ
Williams et al, 2007 [71] (paranoid patients) 13/13 Implicit Fearful.Neutral faces Gender, age, handedness, IQ
Williams et al, 2007 [71] (non-paranoid
patients)
14/13 Implicit Fearful.Neutral faces Gender, age, handedness, IQ
Gur et al, 2007 [72] 16/17 Emotion discrimination task Fearful.Neutral faces Gender, handedness, parental education
Das et al, 2007 [73] 14/14 Implicit and Explicit Fearful.Neutral Gender, age, handedness
Surguladze et al, 2006 [74] 15/11 Implicit Fearful.Neutral faces Gender, age, handedness, education
Holt et al, 2006 [75] 15/16 Implicit Fearful.Neutral Gender, age, education, parental education
Kosaka et al, 2002 [76] 12/12 Emotional intensity
judgment task
Negative.Neutral faces Gender, age, handedness
doi:10.1371/journal.pone.0025322.t001
Table 2. Clinical description of patients with Autism Spectrum Disorders included in facial emotion recognition studies.
Reference
Mean age (SD)
Patients/Controls
Gender (% male)
Patients/Controls
Symptom Scales Mean
score (SD)
Diagnosis/Recruitment/Illness
Duration
Medication Dose
(mg): mean (SD)*
Hall et al, 2010 [60] 31.8/32 100%/100% ADOS (Communication):
5.22 (1.39) ADOS (Social
interaction): 10.33 (2.73)
HFA, Asperger, PDD-NOS No information
provided
Monk et al, 2010 [61] 26/27 100%/100% ADI-R/ADOS HFA (n=7), Asperger(n=2),
PDD-NOS (n=3)
SSRI (n=5),
stimulants (n=4),
NLP (n=2), TCA
(n=1),BZD (n=1)
Deeley
et al, 2007 [62]
34 (10)/27(5) 100%/100% ADI-R/ADOS Asperger Unmedicated
Ashwin
et al, 2007 [63]
31/25 100%/100% Autism Quotient:
35.6 (6.3)
HFA/Asperger Unmedicated
Critchley
et al, 2000 [64]
37(7)/27(7) 100%/100% ADI-R HFA (n=2), Asperger (n=7) No information
provided
ADI-R=Autism Diagnostic Interview-Revised [77]; ADOS=Autism Diagnostic Observation Schedule [78]; BZD=benzodiazepine; HFA=High Functioning Autism; PDD-
NOS=Pervasive Developmental Disorder Not Otherwise Specified; NLP=neuroleptics; SSRI=selective serotonin reuptake inhibitor; TCA=tricyclic antidepressant.
doi:10.1371/journal.pone.0025322.t002
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order to examine their effect on the ALE results.
Results
The initial search returned 415 citations. Of these, 337 studies
were discarded after reviewing the abstracts while the full text of
the remaining 76 citations was examined in more detail. Thirty
three studies fulfilled the inclusion criteria and were included in
the meta-analysis. Details are shown in Tables 1 and 2.
Facial emotion recognition
We identified 16 FER studies in ASD and 33 in SZ, of which 5
and 12 respectively were used in the ALE analysis. The total
sample comprised 55 ASD and 203 SZ patients and 253 healthy
controls (HC) (Table 1). Demographic details for all participants
and clinical information of ASD and SZ patients are shown in
Tables 2 and 3. Mean age did not differ between diagnostic groups
(ASD: mean=31.96, SD=4.06; SZ: mean=31.41, SD=8.47;
t=0.13, df=16, p=0.89,), but there was an over-representation
Table 3. Clinical description of patients with Schizophrenia included in facial emotion recognition studies.
Reference
Age Mean (SD)
Patients/Controls
Gender (% male)
Patients/Controls
Symptom Scales Mean
score (SD)
Diagnosis/Recruitment/Illness
Duration
Medication Dose
(mg): mean (SD)*
Rauch et al, 2010 [65] 27.7 (7.5)/26.9 (6.1) 58.3%/75% PANSS Positive: 14.4 (3.1);
PANSS Negative: 18.9 (5.2);
PANSS General: 34.9 (5.9)
Inpatients NLP: 902.1 (603.2)
Dowd et al, 2010 [66] 36.25 (10.85)/36.8 (8.99) 65.2%/65% SAPS: 1.83 (.93);
SANS: 1.81 (1.37)
Schizophrenia/schizoaffective
disorder outpatients.
Duration of illness: 17.73
years (11.25).
NLP: 452.20 (369.60)
Seiferth et al, 2009 [67] 17.8 (1.4)/17.9 (1.5) 100%/100% PANSS Positive:
16.2 (8.1); PANSS
Negative: 13.3 (8.9)
Early onset schizophrenia, Mean
duration of illness: 38 weeks
NLP: 231 (111)
Reske et al, 2009 [68] 31.94 (6.41)/31.94 (6.03) 55.5%/55.5% PANSS Positive:
8 (1.14); PANSS
Negative: 13.61
(4.47); PANSS
total: 23.11 (3.94)
First episode psychosis,
inpatients
Double blind
treatment with
haloperidol (mean
dose 2.56mg/d) or
risperidone (mean
dose 2.23 mg/d) for 6
to 8 weeks
Michalopoulou
et al, 2008 [69]
35 (9)/32 (6) 81.2%/55.5% PANSS positive:
16 (6.72); PANSS
negative: 13.91
(5.54); PANSS
total: 58.91 (17.72)
Outpatients. Duration of
illness: 12 years (9)
NLP: 523 (455)
Hall et al, 2008 [70] 37.7 (8.4)/35.1 (9.7) 63.15%/66.6% PANSS Positive: 12.3 (4.5) Inpatient and
outpatients. OPCRIT criteria
NLP: 496 (377)
Williams et al, 2007 [71]
(paranoid patients)
26.9 (9.1)/25.1 (8.1) 61.5%/63% PANSS positive
(delusions):5.2 (1.2);
(excitement): 3.7 (0.6)
Duration of illness:
5.6 years (4.6)
NLP: 375.1 (290.6)
Williams et al, 2007 [71]
(non-paranoid patients)
27.8 (10.4)/25.1 (8.1) 64.3%/63% PANSS Positive
(delusions): 2.1
(1.1); 1.6 (0.8)
Duration of illness:
5.6 years (4.6)
NLP: 339.3 (240.3)
Gur et al, 2007 [72] 30.1 (6.5)/25 (3.9) 75%/70.6% SAPS: 1.4 (0.6);
SANS: 1.3 (0.9)
Duration of illness:
9.6 years (7.1),
hospitalizations: 3.6 (4.1)
Untreated (n=1); First
generation NLP
(542 mg/day (292))
(n=2); Olanzapine
(18.2 mg/day (2.8))
(n=11); Both (n=2).
Das et al, 2007[73] 20.4 (3.3)/23.1 (5.9) 100%/100% PANSS Positive:
16.07 (7.24); PANSS
Negative: 21.14 (7.9)
First episode psychosis,
Duration of illness: 1.21
years (1.2)
Unmedicated (n=5);
Atypical NLP, 393.4
(213.2) (n=9)
Surguladze
et al, 2006 [74]
43.1 (8.8)/36.8 (10.6) 100%/100% SAPS: 25.1 (23.9);
SANS: 27.9 (14.6)
Duration of illness: 19.9 years
(10.5), hospitalizations 5.7 (5.4)
NLP: 487.1 (range: 100–
1200 mg/day)
Holt et al, 2006 [75] 47.7 (7.1)/48.2 (9.6) 100%/100% PANSS Positive and
Negative Syndrome
Scale: 59.8 (10.3)
Outpatients. Duration of
illness: 21.6
years (9.6)
NLP: 424.5 (268.8)
Kosaka et al, 2002 [76] 26 (4.5)/24.4 (2.4) 50%/50% PANSS Positive:
11-3 (4.6); PANSS
Negative: 16.3
(4.5); PANSS
General: 28.8 (7.3)
Outpatients and inpatients.
Duration of illness:
3.8 years (3.5)
NLP: 322.0 mg (264.1)
Unmedicated (n=2)
Unless otherwise specified, neuroleptic dose expressed in chlorpromazine equivalents; NLP=neuroleptics; PANSS=Positive and Negative Syndrome Scale for
Schizophrenia [79]; SAPS=Scale for the Assessment of Positive Symptoms [80]; SANS=Scale for the Assessment of Negative Symptoms [81];
doi:10.1371/journal.pone.0025322.t003
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males; chi-square=20.4, df=1, p,0.001).
Autism spectrum disorders vs. healthy controls. During
the emotional faces.neutral faces contrast (ASD=34,
HC=34, foci=9), ASD patients compared to HC showed
increased activation in temporal regions near the STS and
decreased activation in the primary somatosensory cortex,
within the postcentral gyrus. The corresponding anatomical
regions and peak ALE maxima are show in Table 4 and
Figure 1.
Table 4. Activation likelihood estimation results for facial emotion recognition in patients with schizophrenia or autism spectrum
disorders compared to healthy controls.
Brain region Gyrus BA Laterality Site of maximum ALE* Volume (mm
3) Maximum ALE value
xyz
Autism spectrum disorders
ASD.HC
Temporal Superior Temporal 42/22 Left 256 224 6 424 0.01067
ASD,HC
Parietal Postcentral 3 Left 240 220 50 320 0.01286
Schizophrenia
SZ.HC
No significant clusters - - - - - - - -
SZ,HC
Frontal Inferior Frontal 47 Right 36 18 218 80 0.09672
Limbic Posterior Cingulate 23 Right 4 226 24 80 0.00872
Limbic Amygdala Left 222 22 212 96 0.01012
Occipitopemporal Fusiform 19 Right 28 274 210 200 0.01012
Thalamus Dorsomedial Left 22 212 12 208 0.01018
*x=sagittal, y=coronal, z=axial coordinates according to Talairach and Tournoux; BA=Brodmann Area; ALE=Activation Likelihood Estimation, p,0.05 False Rate
Discovery corrected for multiple comparisons. SZ=Schizophrenia, ASD=Autism Spectrum Disorders, HC=Healthy Controls.
doi:10.1371/journal.pone.0025322.t004
Figure 1. Activation likelihood estimation maps comparing autism spectrum disorder subjects with healthy controls. Clusters of
relative underactivation or overactivation in ASD are shown in blue and red respectively; numbers represent the sagittal (x), coronal (y) and axial (z)
coordinates of each slice in Talairach space. p,0.05 False Rate Discovery corrected for multiple comparisons. ASD=Autism Spectrum Disorders,
HC=Healthy Controls.
doi:10.1371/journal.pone.0025322.g001
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contrast (SZ=77, HC=77, foci=16), SZ patients compared to
HC showed decreased activation in the ventrolateral PFC, posterior
cingulate cortex, amygdala, occipito-temporal regions (encompassing
the fusiform gyrus) and thalamus (Table 4, Figure 2).
Comparison of autism spectrum disorders and
schizophrenia. ASD subjects were significantly more likely than
SZ to engage temporal regions near the STS and in the anterior and
posterior cingulate cortex. In the inverse contrast, SZ patients
expressed greater likelihood than ASD to engage the ventrolateral
Figure 2. Activation likelihood estimation maps comparing schizophrenia patients with healthy controls. Clusters of relative
underactivation or overactivation in SZ are shown in blue and red respectively; numbers represent the sagittal (x), coronal (y) and axial (z) coordinates
of each slice in Talairach space. p,0.05 False Rate Discovery corrected for multiple comparisons. SZ=Schizophrenia, HC=Healthy Controls.
doi:10.1371/journal.pone.0025322.g002
Table 5. Activation likelihood estimation results for facial emotion recognition comparison of schizophrenia and autism spectrum
disorders.
Brain region Gyrus BA Laterality Site of maximum ALE
Volume
(mm
3)
Maximum
ALE value
xyz
Autism Spectrum Disorders.Schizophrenia
Limbic Anterior Cingulate 24 Left 0 26 20 392 0.00652
Limbic Anterior Cingulate 32 Right 10 34 20 376 0.00652
Limbic Posterior Cingulate 30 Left 220 262 4 320 0.00645
Temporal Superior Temporal 42/22 Left 256 224 6 1824 0.00884
Temporal Superior Temporal 22 Right 40 248 14 432 0.00663
Schizophrenia.Autism Spectrum Disorders
Frontal Inferior Frontal 47 Left 236 28 2 392 0.00646
Limbic Parahippocampus 28 Left 222 222 210 392 0.00629
Parietal Inferior Parietal 40 Left 250 244 240 360 0.00647
Occipital Inferior Occipital 18 Right 32 284 24 304 0.00646
Cerebellum Culmen - Left 230 246 220 352 0.00654
Cerebellum Culmen - Right 32 244 218 304 0.00639
Cerebellum Declive - Left 230 276 220 384 0.00651
Cerebellum Declive - Right 26 68 214 376 0.00651
x=sagittal, y=coronal, z=axial coordinates according to Talairach and Tournoux. BA=Brodmann Area; ALE=Activation Likelihood Estimation, p,0.05 False Rate
Discovery corrected for multiple comparisons.
doi:10.1371/journal.pone.0025322.t005
Social Cognition in SZ and ASD
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e25322PFC, the parahippocampal gyrus and regions within the TPJ, inferior
occipital gyrus and the cerebellum (Table 5, figure 3).
Theory of mind
Our search identified 10 studies exploring ToM related processes
in ASD subjects and 17 in SZ patients, of which 7 and 9 respectively
fulfilled inclusion criteria (Table 6). The total analysis encompassed
91 ASD and 133 SZ patients, and 239 HC subjects. Demographic
details for all participants and clinical information corresponding to
ASD and SZ patients are shown in Tables 7 and 8. ASD subjects
weresignificantlyyoungerthan SZ (ASD:mean=18.55, SD=7.03;
SZ: mean=31.36, SD=4.08; t=4.1, df=13, p=.001), and
included a higher percentage of males (ASD: mean=95.2%,; SZ:
mean=63.0%, chi-quare=47.01, df=1, p,0.001).
Autism spectrum disorders vs. healthy controls. In the
contrast ToM.control condition (ASD=88, HC=98, foci=33),
ASD subjects compared to HC showed decreased activation in six
clusters located in the medial prefrontal and in the anterior
cingulate cortex, the amygdala and in primary and secondary
somatosensory areas in the precentral gyrus, the STS, and in the
TPJ within the inferior parietal lobule (Table 9, Figure 1).
Schizophrenia vs. healthy controls. In the same contrast
(SZ=133, HC=140, foci=43) SZ patients compared to HC
showed (a) increased activation in the posterior cingulate cortex
and within the somatosensory cortices in the paracentral lobule,
and superior temporal gyrus and (b) decreased activation in the
medial prefrontal PFC, middle temporal gyrus and the thalamus
(Table 9, Figure 2).
Comparison of autism spectrum disorders and
schizophrenia. ASD was associated with greater likelihood of
activation in the insula compared to SZ (Table 10). In the inverse
contrast, SZ was associated with greater likelihood of engagement
in regions within the medial PFC and somatosensory areas in the
paracentral gyrus, and in the posterior cingulate cortex (Table 8;
Figure 3). The effect size of signal differences in the medial PFC
region was positively correlated with age (peak coordinates=226,
50, 2; r
2=0.28; p=0.001; voxels=59).
Examination of confounding factors
Age. The effect size of signal differences in the medial PFC
region was positively correlated with age (peak coordinates=226,
50, 2; r
2=0.28; p=0.001; voxels=59). This would suggest that
some of the differences observed between ASD and SZ in this area
may be also modulated by age.
Antipsychotic medication. Details of pharmacological
treatments are displayed in tables 2 and 4. The mean dose of
antipsychotic drugs was converted into chlorpromazine equivalent
doses. Studies providing information on the mean daily chlorp-
romazine equivalent dose of antipsychotics for their sample were
included in voxel-wise meta-regressions exploring the relationship
between dose and magnitude of ALE scores. Antipsychotic
medications were found to have a normalizing effect on amygdala
involvement during FER. The effect size of signal differences in the
amygdala was negatively correlated with dose of antipsychotics (peak
coordinates: [30, 22, 218]; r
2=0.48; p=0.001; number of voxels=
45), and therefore it is unlikely that the differences observed between
ASD and SZ are due to the effects of antipsychotic medication. With
regards to ToM, we also found an ameliorative effect of medication on
the activation in the superior temporal gyrus (peak voxels: [46, 10,
224]; r
2=0.48; p=0.001; number of voxels=237; and [44, 16, 12];
r
2=0.27; p=0.001; number of voxels=171), which we also interpret
as unlikely to be the source of the group differences.
Discussion
We used quantitative analysis to explore the neural correlates
of social cognition during facial emotion recognition (FER) and
theory of mind (ToM) tasks in ASD and SZ. Differential effects
Figure 3. Activation likelihood estimation maps comparing autism spectrum disorder with schizophrenia patients. Clusters of relative
overactivation and underactivation in ASD are shown in green and yellow respectively; numbers represent the sagittal (x), coronal (y) and axial (z) coordinates
of each slice in Talairach space. p,0.05 False Rate Discovery corrected for multiple comparisons. ASD=Autism Spectrum Disorders, SZ=Schizophrenia.
doi:10.1371/journal.pone.0025322.g003
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direction of the findings. Our key findings can be summarised as
follows: (a) Both SZ and ASD patients showed reduced
engagement in medial PFC regions, with the extent and degree
of deficit being greater in ASD; conversely, ventrolateral PFC
disruption was associated mostly with SZ, (b) SZ was associated
with hyperactivation in somatosensory cortices, while ASD
subjects showed reduced activity in these regions, (c) amygdala
hypoactivation was observed in SZ patients during facial
emotion processing and in ASD during more complex ToM
tasks, (d) both SZ and ASD were associated with decreased
engagement of regions around the STS during ToM tasks, but
when processing facial affect, overactivation in these regions was
noted in ASD, (e) reduced thalamic engagement was uniquely
associated with SZ.
Prefrontal and midline cortical involvement
We found both similarities and differences in prefrontal
engagement in ASD and SZ. During FER tasks, SZ patients were
significantly more likely than ASD to engage the ventrolateral
PFC, but the degree of activation was less than in controls. Both
SZ and ASD were associated with hypoactivation in medial PFC
regions during ToM tasks, although the deficits were quantitatively
greater in ASD and extended more posteriorly into the anterior
and posterior cingulate cortex.
The role of the ventrolateral PFC in social cognition has begun to
be more fully appreciated as it is involved in multiple tasks of social
cognition [17]. This region is thought to modulate the influence of
emotional stimuli on cognition with respect to contextually (or
socially) appropriate behaviour [12,18,19,36]. Our findings of
hypoactivation in SZ patients in this region reinforce the results of
Leitman and colleagues [37] who demonstrated reduced contextual
modulation of the ventrolateral PFC in SZ in connection to impaired
affective appraisal. In contrast, activation in the medial prefrontal
cortex is thought to underlie emotion generation, particularly when
assessing self-relevant attributes or emotional awareness [38–40].
Therefore our results imply that reduced PFC engagement in
connection to the social appropriateness of behaviour may be more
relevant to SZ, while in both SZ and ASD, reduced medial PFC
engagement may contribute to abnormalities in conscious awareness
of the emotional states of others.
Somato-sensory cortices
Activation in primary and secondary somato-sensory cortices
was reduced in ASD, in comparison to controls and SZ patients,
during both FER and ToM tasks. Engagement of somato-sensory
cortices is thought to invoke (‘‘mirror’’) bodily states associated
with pertinent emotions or other internal states, thus facilitating
their recognition in oneself or others [11,41,42]. Our findings in
ASD are consistent with reports of abnormal cortical thickness and
Table 6. Details of studies included in the meta-analysis for theory of mind tasks.
Reference Patients/Controls Task Contrast used Matching
Autism spectrum disorders
Lombardo et al, 2010 [82] 23/23 Judgment of self or other
physical or mental states
Other mentalising.Self
mentalising
Gender, age, IQ, handedness
Uddin et al, 2008 [83] 8/12 Self face recognition paradigm Self.Rest Gender, age, IQ, handedness
Wang et al, 2007 [84] 18/18 Judgment of irony Irony.No Irony conditions Gender, age, handedness
Dapretto et al, 2006 [85] 10/10 Imitation of facial expressions Imitation of facial
expressions.Passive observation
Gender, age, IQ
Williams et al, 2006 [86] 16/15 Imitation of facial expression Imitation.Observation of
animated facial expressions
Gender, age, IQ, handedness
Pelphrey et al, 2005 [87] 10/9 Judgment of congruency of
eye gaze shift
Incongruent.Congruent
gaze shift
Gender, age, IQ, handedness
Baron-Cohen et al, 1999 [53] 6/12 Judgment of mental states
from pictures of eyes
Judgment of mental
state.Judgment of gender
Gender, age, IQ, handedness,
socioeconomic status, education
Schizophrenia
Park et al, 2011 [88] 14/15 Listening and viewing of self
or other referential vignettes
Other referential.Neutral Gender, age, handedness, education
Lee et al, 2010 [89] 15/18 Empathic story completion
task
Empathic.Factual Gender, age, verbal IQ, handedness,
education
Holt et al, 2010 [90] 17/18 Self or other referential affect
labeling, and perceptual
processing of adjectives
Other referential.Perceptual
processing
Gender, age, IQ, handedness,
ethnicity, parental socio-economic
status
Walter et al, 2009 [48] 12/12 Intentional story completion
task
Intentional.Factual causality Gender, age, handedness, education
Benedetti et al, 2009 [91] 24/20 Judgment of intentions
or empathy
Intention and empathy.Physical
causality
Gender, age, handedness
Dollfus et al, 2008 [92] 23/23 Judgment of corruption Judgment of corruption.Factual Gender, age, handedness, education
Brune et al, 2008 [93] 9/13 Judgments of cooperation
or deceit
Mentalising judgment.Factual
judgment
Gender, age, handedness
Lee et al, 2006 [94] 14/14 Judgment of empathy Empathic.Factual judgments Gender, age, handedness, IQ
Russell et al, 2000 [95] 5/7 Judgment of mental states
from pictures of eyes
Judgment of mental
state.Judgment of gender
Gender, age, handedness, education
doi:10.1371/journal.pone.0025322.t006
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regions [43,44] and lend further support to the notion that ASD is
associated with dysfunction in invoking ‘‘mirroring’’ mechanisms
when processing social stimuli [45]. Our evidence of increased
involvement of somato-sensory regions during social cognitive
tasks in SZ adds to similar findings [46,47], and may contribute to
the over-attribution of agency and ‘‘hypermentalization’’ de-
scribed in schizophrenia [48,49].
Amygdala
Decreased engagement of the amygdala was observed in SZ
patients during FER tasks, which confirms findings from earlier
meta-analytic studies [28,50]. However, Anticevic et al [50]
have reported that in SZ there is increased amygdala activation
to neutral stimuli, which may have reduced the contrast
between emotional and neutral conditions employed here. In
ASD subjects, amygdala hypoactivation was observed during
ToM tasks, in line with previous reports of significant amygdala
pathology in autism [51–53]. Ourr e s u l t ss u g g e s tt h a tb o t hS Z
and ASD show deficits in engaging the amygdala when
processing social stimuli, but this observation may depend on
stimulus type. In SZ, reduced amygdala activation was
associated with tasks of attribution of affective states, while in
ASD it was mostly seen during tasks of epistemic and intentional
attributions. We can only speculate as to the underlying
mechanisms of this stimulus-specific dissociation of amygdala
engagement in SZ and ASD.
Theamygdalaisnot ahomogeneousstructure butiscomprised of
13 nuclei. The functional specificity of the amygdala nuclei remains
unclear, since selective lesions in humans have not been reported.
Despite evidence that damage to basal and lateral nuclei may be
more directly linked to recognition of facial expressions [54,55] it is
not known whether there is regional specialisation within the
amygdala for processing other social stimuli. However, our data
suggest that the possibility of disease specific regional pathology in
SZ and ASD may be worth pursuing in future studies.
Lateral and ventral temporal regions
Both SZ and ASD were associated with similar hypoactivation
in temporal regions around the STS during ToM tasks; however
ASD patients showed increased engagement in this region
compared to controls and to SZ patients during FER.
Temporal lobe regions near the STS are thought to be involved
in the representation of biologically salient cues relating to goal-
directed movement [22] including the configural and changeable
properties of human faces [56]. Processing of this information in
regions around the STS is thought to assist in formulating
attributions about the intentional states of others [23,57].
Our results suggest that processing information relating to ToM
tasks was associated with similar reduction in engagement within
these regions both in SZ and ASD. However, we also found
evidence that STS engagement may differ between disorders based
on stimulus type, as ASD patients showed overactivation in these
regions during FER. Reduced activation in regions around the STS
(extending to the fusiform gyrus) has been noted in ASD patients
during person identification tasks (i.e. memorising and recalling
information about the identity of a face); however person
identification is not required in facial emotion recognition
paradigms which rely on decoding the ‘‘social’’ (i.e. emotional)
cues conveyed by facial expression. Our results resonate with
previous reports that patients with ASD rely excessively on facial
featureextractionduringfacialprocessing[51] and suggestthatthey
probably use a ‘‘logical’’ rather than a ‘‘social’’ approach to dealing
with human facial expressions. Our findings reinforce the
dependence of functional changes in ASD on the type of stimulus
and also the specific task requirements which would be useful in
informing and refining future study designs.
Thalamus
Decreased engagement of the thalamus during social cognition
was found mostly in connection to SZ, implicating the dorsome-
dial and pulvinar nuclei. The thalamus provides a nodal link for
multiple functional circuits coordinating the flow of information in
Table 7. Clinical description of patients with Autism Spectrum Disorders included in theory of mind studies.
Reference
Mean age (SD)
Patients/Controls
Gender (% male)
Patients/Controls
Symptom Scales Mean
scores (SD)
Diagnosis/Recruitment/
Illness Duration
Medication Dose (mg):
mean (SD)*
Lombardo
et al, 2010 [82]
27.97 (6.10)/26.59 (7.04) 100% ADI-R: (Social): 18.07 (5.07),
(Communication): 15.17
(4.24), (Rep): 5.97 (2.76)
AQ (ASD): 32.59 (8.20);
AQ (HC): 15.24 (6.89)
Asperger Syndrome No information provided
Uddin et al, 2008 [83] 13.19 (2.61)/12.23 (2.1) 100% ADOS, ADI-R HFA None
Wang et al, 2007 [84] 11.8 (2.9)/11.8 (1.9) 100% ADOS, ADI-R, Social
Responsiveness Scale
HFA Medicated (SSRIs,
stimulants, atypical NLP)
(n=7)
Dapretto et al, 2006 [85] 12.05 (2.5)/12.38 (2.2) 100% ADOS (Social) 8.5 (3.0); ADI
(Social): 20.3 (4.9)
HFA No information provided
Williams et al, 2006 [86] 15.4 (2.24)/15.5 (1.60) 100%/100% ADOS, ADI-R HFA Methylphenidate (n=2),
clonidine,
dexamphetamine and
melatonin (n=1)
Pelphrey et al, 2005 [87] 23.2 (9.9)/23.4 (5.8) 90%/89% ADOS, ADI-R HFA No information provided
Baron-Cohen
et al, 1999 [53]
26.3 (2.1)/25.5 (2.8) 67%/50% DSM-IV, ICD-10 HFA No information provided
ADI-R=Autism Diagnostic Interview-Revised [77]; ADOS=Autism Diagnostic Observation Schedule [78]; AQ=Autism Spectrum Quotient [96]; DSM-IV=Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition; HFA=High Functioning Autism; ICD-10=International Classification of Diseases, 10
th Revision; NLP=neuroleptics;
SSRI=selective serotonin reuptake inhibitor.
doi:10.1371/journal.pone.0025322.t007
Social Cognition in SZ and ASD
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e25322a range of higher cognitive and sensory processes. The pulvinar is
is considered a ‘‘higher order’’ nucleus because of its widespread
bidirectional cortical connections; it is directly involved in visual
perception, particularly in directing and maintaining attention
towards salient stimuli. The involvement of the dorsomedial
thalamus in social cognition is mostly considered within the
context of its general contribution to executive functions through
its connections with the prefrontal cortex. Extensive thalamic
pathology both in terms of microstructure, gross anatomy and
functional engagement have been consistently reported in SZ [49].
Our findings extend this literature to include thalamic dysfunction
to social cognition tasks.
Methodological considerations
Although Activation Likelihood Estimation represents a pow-
erful approach for the meta-analytic treatment of neuroimaging
data, a number of factors should be considered in the
interpretation of the current set of findings. First, comparison of
neuroimaging studies between SZ and ASD is complicated by the
variability of the activation paradigms used. We attempted to
minimise this by grouping together paradigms that map on to
different domains of social cognition and then examining them
separately. This was possible for studies investigating attribution of
affective states using facial expressions. However, given the
variability of the ToM paradigms we followed the approach of
other meta-analytic studies, which have also pooled several related
domains of cognition together [31,58]. Second, we accepted the
results of individual original studies as reported, since ALE
analyses do not allow for weighting based on the threshold of
significance employed in each original study. Some studies have
reported coordinates extracted from pre-specified regions of
interest; this may have inflated the weight assigned to the findings
regarding the amygdala and fusiform gyrus (FER studies), and
medial prefrontal cortex, cingulate and STS (ToM studies). Third,
ASD and SZ patients differ in their symptom profiles, with
psychotic symptoms being predominantly associated with the
diagnosis of SZ. Previous studies have suggested that the presence
or absence of positive symptoms may contribute to the distribution
and degree of functional disruption in SZ during social cognition
[59]. The contribution of psychotic symptoms to the present
findings is unclear. Nevertheless, the majority of SZ studies
included patients that would be generally regarded as being in
remission. Fourth, we have documented effects of antipsychotic
medication on signal differences in several brain regions; however,
these effects are predominantly ameliorative (i.e. reduced the effect
size of group differences), and are thus unlikely to account for the
differences observed between groups. Fifth, although gender
differences have been found during social cognition tasks [58] it
was not possible to examine this directly because the predomi-
nance of male participants in ASD studies did not allow gender-
specific analysis of the available data. Fifth, age differences
between the diagnostic groups may have influenced our findings,
Table 8. Clinical description of patients with Schizophrenia included in theory of mind studies.
Reference
Mean age (SD)
Patients/Controls
Gender (% male)
Patients/Controls
Symptom Scales
Mean scores (SD)
Diagnosis/Recruitment/Illness
Duration
Medication Dose (mg): mean
(SD)*
Lee et al,
2010 [89]
26.0 (4.3)/25.8 (2.2) 47%/50% PANSS Positive=13.1 (5.1);
PANSS Negative=15.4 (4.1);
PANSS Total=64.4 (11.0)
Stable outpatients; Duration of
illness: 4.6 years (3.4)
422.1 (23.7); Olanzapine (n=4),
aripirazole (n=4), risperidone
(n=2), amisulpride (n=2),
clozapine (n=1), perphenacine
(n=1), ziprasidone (n=1)
Holt et al,
2010 [90]
35.9 (13.7)/40.0 (12.5) 65%/67% PANSS Positive=11.7 (3.6);
PANSS Negative=11.4 (3.2);
PANSS General=24.2 (5.2);
PANSS Total=47.3 (10.0)
Stable outpatients; Duration of
illness: 13.2 years (12.8)
NLP 374.1 (364.0)
Walter et al,
2009 [48]
29.5 (6.9)/24.7 (2.6) 50%/50% PANSS Positive=17.75 (5.06);
PANSS Negative=19.41 (3.96);
PANSS Total=73.75 (11.02);
Brief Psychiatric Rating
Scale=47.18 (10.6)
Inpatients; Duration of
illness: 6.3 years (5.2)
No information provided
Benedetti et al,
2009 [91]
37.2 (10.23)/35.1 (9.95) 58%/5% PANSS Positive=16 (4.58);
PANSS Negative=21.66
(5.42); PANSS
Total=72.57 (14.49)
Stable outpatients; SZ
subtypes: undifferentiated
(n=9), paranoid (n=13),
disorganized (n=2); Duration
of illness: 12.7 years (6.96)
357.81 (256.17). Monotherapy,
stable doses for prior 3 months.
Clozapine (n=9), risperidone
(n=11), aripiprazole (n=2),
haloperidol (n=2).
Dollfus et al,
2008 [92]
29.9 (7.9)/30.0 (8.6) 78%/78% PANSS Positive=11.7 (4.5);
PANSS Negative=13.1 (5.0);
PANSS Total=49.5 (14.8)
Stable outpatients;. Duration
of illness: 7.6 years (7.2)
NLP: 315.5 (256.2)
Brune et al,
2008 [93]
27.89(6.6)/26.46(5.30) 33%/31% PANSS Positive=16.67 (5.75);
PANSS Negative=15.67 (8.87)
First Episode (n=6), recurrent
episodes (n=3); Duration of
illness: 3.0 years (4.23)
NLP:244.44 (173)
Lee et al,
2006 [94]
31.7(7.3)/30.5(8.8) 93%/93% SAPS=2.4 (2.0);
SANS=5.4 (3.0)
Outpatients; Duration of
illness: 9.8 years (5.4)
406.4 (205.6); Clozapine (n=5),
olanzapine (n=4), risperidone
(n=1), typical NLP (n=4).
Russell et al,
2000 [95]
36 (9)/40(11) 100%/100% DSM-IV criteria Duration of illness: 13 years (7) Receiving NLP
Unless otherwise specified neuroleptic dose expressed in chlorpromazine equivalents; duration of illness is presented as mean (standard deviation); DSM-IV=Diagnostic
and Statistical Manual of Mental Disorders, 4th Edition; NLP=neuroleptics; PANSS=Positive and Negative Syndrome Scale for Schizophrenia [79]; SAPS=Scale for the
Assessment of Positive Symptoms [80]; SANS=Scale for the Assessment of Negative Symptoms [81].
doi:10.1371/journal.pone.0025322.t008
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younger than SZ patients. Indeed, an effect of age was observed in
prefrontal regions, favouring SZ. Sixth, the average sample size
per study was generally small. This suggests that individual studies
may be prone to Type II errors, but also that our results represent
the most robustly replicated group differences. Finally, our meta-
analysis provides an estimate of how consistently clusters of
differential activation occur in particular brain regions when
comparing groups of individuals (e.g. SZ vs. controls), and not the
mean activation difference in these regions. Therefore traditional
measures of heterogeneity and publication bias that are based on
the effect size of group differences are not applicable.
Conclusions
In sum, the present results shed light on the neural correlates of
social cognition in SZ and ASD and identify differences and
similarities between the disorders. In the context of the current
debate with regard to diagnostic boundaries, we hope that these
findings will facilitate the formulation of new pathophysiological
hypotheses and aid the design of future studies.
Table 9. Activation likelihood estimation results for theory of mind in patients with schizophrenia or autism spectrum disorders
compared to healthy controls.
Brain Region Gyrus BA Laterality Site of maximum ALE Volume (mm
3) Maximum ALE value
xyz
Autism Spectrum Disorders
Autism Spectrum Disorder.Healthy Controls
No significant clusters - - - - - - - -
Autism Spectrum Disorder,Healthy Controls
Frontal Medial Frontal 9/10 Left 22 52 28 176 0.01022
Frontal Precentral 44 Right 54 8 8 96 0.00939
Limbic Anterior Cingulate 24 Left 22 22 40 248 0.01126
Limbic Amygdala Left 222 28 28 272 0.01309
Temporal Middle Temporal 21 Left 256 236 0 176 0.01038
Parietal Inferior Parietal 40 Left 238 232 48 344 0.01117
Schizophrenia
Schizophrenia.Healthy Controls
Parietal Paracentral Lobule 5 Right 2 238 54 176 0.00946
Limbic Posterior Cingulate 23 Left 0 216 24 88 0.00971
Schizophrenia.Healthy Controls
Frontal Medial Frontal 9/10 Left 26 50 26 64 0.00922
Limbic Posterior Cingulate 23 Right 10 232 22 232 0.01019
Temporal Middle Temporal 22 Left 258 236 4 120 0.00978
Thalamus Pulvinar Left 26 232 8 272 0.01134
x=sagittal, y=coronal, z=axial coordinates according to Talairach and Tournoux; BA=Brodmann Area; ALE=Activation Likelihood Estimation, p,0.05 False Rate
Discovery corrected for multiple comparisons.
doi:10.1371/journal.pone.0025322.t009
Table 10. Activation likelihood estimation results for theory of mind tasks comparison of schizophrenia and autism spectrum
disorders.
Brain region Gyrus BA Laterality Site of maximum ALE Volume (mm
3) Maximum ALE value
xy z
Autism Spectrum Disorders.Schizophrenia
Limbic Insula 13 Right 32 22 12 200 0.00636
Schizophrenia.Autism Spectrum Disorders
Frontal Medial Frontal 10 Right 8 60 4 168 0.00627
Frontal Paracentral Lobule 5 Left 0 236 52 656 0.00784
Limbic Posterior Cingulate 23 Left 0 216 24 624 0.00706
Limbic Posterior Cingulate 31 Left 26 230 34 200 0.00665
x=sagittal, y=coronal, z=axial coordinates according to Talairach and Tournoux; BA=Brodmann Area; ALE=Activation Likelihood Estimation, p,0.05 False Rate
Discovery corrected for multiple comparisons.
doi:10.1371/journal.pone.0025322.t010
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